Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers. [PDF]
Kirou RA +18 more
europepmc +1 more source
The clinical, serological and myopathological features of a cohort of Chinese patients with inclusion body myositis: a single center analysis. [PDF]
Qiu H +13 more
europepmc +1 more source
Inclusion Body Myositis, a Review [PDF]
openaire +2 more sources
Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement. [PDF]
Torchia E +15 more
europepmc +1 more source
Development and Validation of the Inclusion Body Myositis-Health Index: A Disease-Specific Patient-Reported Outcome Measure for Use in Clinical Trials and Drug-Labeling Claims. [PDF]
Irwin C +12 more
europepmc +1 more source
Quadriceps and ankle weakness in inclusion body myositis: impact on descending balance control and rehabilitation strategies - a systematic review. [PDF]
Jeon W, Dalby A, Hermanns M, Lubinus M.
europepmc +1 more source
Spatial protein expression patterns across pathologically-associated fibers revealed molecular specialization in inclusion body myositis. [PDF]
Nijssen TI +9 more
europepmc +1 more source
cN1A Antibody-Positive Inclusion Body Myositis Following Seminoma Manifesting With Slowly Progressive Paraparesis: A Case Report. [PDF]
Finsterer J.
europepmc +1 more source
Mitochondrial damage is associated with an early immune response in inclusion body myositis. [PDF]
Kleefeld F +21 more
europepmc +1 more source
Alpha-Synuclein as a Potential Biomarker for Inclusion Body Myositis in Blood and Muscle. [PDF]
Mayer T +14 more
europepmc +1 more source

